All your bioinformatics results and experimental data are already on Latch.
With our newest component, Latch Plots, and LLM assistance, we aim to enable scientists to ask questions and get insights instantly. All without ever leaving the platform.
1
4
3,679
To find out how, tune in on October 30th for a live presentation and demonstration from Hannah Le, Head of Product at LatchBio.
Register here to save your spot: us06web.zoom.us/webinar/regi…
1,476
Last month we released our first Product Digest newsletter! Check out our October edition below where we highlight our latest product releases including:
•A Nextflow Integration
•White-labeled customer analysis portals for solution providers
•Support for Bulk RNA-seq, qPCR and ATAC-seq
1
1
1,681
Read the October edition here: open.substack.com/pub/latchb…
Make sure to subscribe to stay tuned for our November edition.
1
846
It was great to talk with Colin Ng, VP of AtlasXomics yesterday during our webinar!
We’ve been fortunate to partner with AtlasXomics to create a toolset that makes their customers’ data analysis automated and accessible without sacrificing flexibility.
1
3
1,500
If you couldn't make it to our live webinar yesterday, you can still watch the recording here: us06web.zoom.us/rec/play/XnY…
842
AtlasXomics is creating beautiful maps at cellular resolution to reveal the epigenetic underpinnings of disease development.
Creating these maps generates 100s of TBs of data and requires a vast computational infrastructure. Tune in to our webinar on Thursday, August 1st to hear from Colin Ng, VP of AtlasXomics, about how they partner with LatchBio to overcome this data challenge and deliver quicker insights to their customers.
Epigenetics is changing our understanding of diseases.
AtlasXomics creates spatial multiomics maps of tissue – generating over 1000 TB of data and serving 70+ labs on LatchBio – to help scientists uncover the epigenetic drivers of disease.
They are pioneering a nascent field with some of the most advanced bioinformatics we’ve ever seen 🤯
Tune in August 1st for a live presentation and Q&A from Colin Ng, Vice President of @AtlasXomics , a pioneer in spatial biology.
Register here to learn more: us06web.zoom.us/webinar/regi…
Congratulations to our partner @FluentBio on their acquisition by Illumina.
The future of single-cell technology is bright.
bit.ly/3XYQdPk
Latch is now SOC 2 Type II compliant! Our team, software, and procedures demonstrated best-in-class security and data privacy practices during the three-month independent audit, including penetration tests.
Cloud security is rightfully a major concern for biotechs modernizing data infrastructure. Visit our Trust Center for thorough overviews of our security and operational safeguards at trust.latch.bio
Congrats to EvolutionaryScale for the release of ESM3, an LLM that uses sequence, structure and function to generate new proteins.
The model is now on Latch for non-commercial use and gives the academic community access to their cutting-edge industrial research with a few clicks.
Google Cloud integration is now available!
This adds to our suite of tools that allow you to BYO data to Latch. Other options include AWS S3 buckets, FTP servers, SRA, Google Drive, HPC, or your local laptop.
All files on Latch get automatic sharing links, no matter the size.
8
1,112
Kits can produce hundreds of GBs of dense text and CSVs 🧬
From these, providers must create digestible visualizations, but creating and hosting these apps at scale is challenging.
Latch now allows Kit providers to deliver unlimited RShiny/Dash apps to customers.
1
1,003
Sign up to be notified when our next webinar is scheduled: form.typeform.com/to/fBUGf3E…
Book a demo to discover how Latch can accelerate your R&D: latchbio2.paperform.co/
445
Join us for our webinar on April 25th to learn how Metagen uses LatchBio to engineer microbes and to generate more food for the world: latch.bio/customer-science-w…
2
484
Today we’re introducing four revolutionary product redesigns.
A New Latch Data, Workflows, Registry, and Pods. New Data, New Workflows... Are you getting it?!
These are not four separate redesigns. We're replacing *the entire platform* with just an AI Chatbot, and we are calling it Latch AI.
We see where the future is headed. No more fussing with buttons, tables, or forms. Upload your data files and Latch will figure out the rest.
Today, Latch is going to reinvent biology, and take biocomputing into the future it deserves.
Check it out at Latch.AI
We’re excited to host a webinar with Elsie Biotechnologies, industry leader and GSK’s partner in oligonucleotide drug discovery, on how to engineer oligonucleotide therapies at unprecedented scale. Register to join us on March 21st to learn more: latch.bio/customer-science-w…
Dillon Flood, Co-Founder & Scientific Director, founded Elsie to bring medicinal chemistry to oligonucleotide therapeutics.
Now, Elsie’s platform technologies target specific brain regions with precision therapeutics to tackle neurological diseases. To learn more: latch.bio/use-cases/oligonuc…
378
We are thrilled to announce that LatchBio is officially HIPAA compliant!⚕️Check out our Trust Center here: trust.latch.bio/
If you would like to learn more about HIPAA, how to sign a BAA, or hear more details on how Latch approaches data security, please let us know via the form here 👉 shorturl.at/eBFLN #biotech
ALT LatchBio is now HIPAA compliant
